Dr. James C. Shanks, MD

Dr. Shanks practices at M Health Fairview St. John's Hospital in Maplewood, Minnesota, part of M Health Fairview.

Dr. Shanks' NPI, 1255393906, was assigned on April 6, 2006. Dr. Shanks graduated from University of Minnesota Medical School in 2002. Dr. Shanks holds Minnesota license 48214.

Dr. Shanks' primary practice is M Health Fairview St. John's Hospital, at 1575 Beam Avenue, Maplewood, MN 55109 in Ramsey County. The practice phone is (651) 232-7000.

Dr. Shanks' primary practice is M Health Fairview St. John's Hospital in Maplewood, Minnesota, part of M Health Fairview. Dr. Shanks is also affiliated with M Health Fairview University of Minnesota Medical Center. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Shanks to 2 more hospitals and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shanks practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Shanks' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Shanks is licensed in Minnesota.

Dmand AI lists breast cancer, chronic anemia, colorectal cancer, lung cancer, lymphoma, multiple myeloma, prostate cancer and purpura and thrombocytopenia among the conditions Dr. Shanks treats.

CMS data shows 544 Medicare services from Dr. Shanks across 7 procedure codes in 2024, for 202 Medicare patients. Medicare paid $29,029 for them.

CMS counts 202 Medicare patients who saw Dr. Shanks in 2024. The largest group is 75 to 84, with 74 patients. 74% of them have high blood pressure, and 67% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shanks' median patient age at 73, with 57% women.

In 2024, Dr. Shanks wrote 1,021 Medicare Part D claims for 222 patients. 85% of them were for generic drugs. CMS names the drug for 671 of them, across 24 drugs with 11 or more claims each, at $372,034 in total drug cost. In 2023, CMS named 715 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Shanks for performance year 2024, reported as part of a group. Dr. Shanks accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shanks as offering telehealth.

Dmand AI links 5 papers to Dr. Shanks, published from 2016 to 2022. 2016 was the busiest year, with 2. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols. Dr. Shanks' most frequent co-authors are Charles M. Rudin, MD, PhD, Chandra P. Belani, MD and Michael Anthony Carducci, MD.

CMS Open Payments shows 12 general payments to Dr. Shanks from 4 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 86% of the total. Eli Lilly and Company paid the most, $113.

Dr. Shanks graduated from University of Minnesota Medical School in 2002.

Dr. Shanks is in network with 9 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Medica. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.